Alzinova AB (publ) (STO:ALZ)
0.8400
+0.0900 (12.00%)
Jul 24, 2026, 5:29 PM CET
Alzinova AB Revenue
Alzinova AB had revenue of 4.95M SEK in the quarter ending March 31, 2026, a decrease of -18.82%. This brings the company's revenue in the last twelve months to 25.66M, up 27.95% year-over-year. In the year 2025, Alzinova AB had annual revenue of 26.80M with 59.44% growth.
Revenue (ttm)
25.66M
Revenue Growth
+27.95%
P/S Ratio
5.92
Revenue / Employee
3.67M
Employees
7
Market Cap
151.98M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 26.80M | 9.99M | 59.44% |
| Dec 31, 2024 | 16.81M | -3.06M | -15.41% |
| Dec 31, 2023 | 19.87M | 3.24M | 19.49% |
| Dec 31, 2022 | 16.63M | -688.70K | -3.98% |
| Dec 31, 2021 | 17.32M | 2.42M | 16.27% |
| Dec 31, 2020 | 14.90M | 8.09M | 118.80% |
| Dec 31, 2019 | 6.81M | -2.55M | -27.26% |
| Dec 31, 2018 | 9.36M | 3.57M | 61.63% |
| Dec 31, 2017 | 5.79M | 526.29K | 10.00% |
| Dec 31, 2016 | 5.26M | 4.26M | 424.31% |
| Dec 31, 2015 | 1.00M | 49.79K | 5.22% |
| Dec 31, 2014 | 954.33K | 43.85K | 4.82% |
| Dec 31, 2013 | 910.48K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| IRLAB Therapeutics AB | 92.46M |
| Xbrane Biopharma AB | 83.30M |
| Nanologica AB | 31.83M |
| Biovica International AB | 13.49M |
| Elicera Therapeutics AB | 10.64M |
| NextCell Pharma AB | 9.24M |
| Xintela AB | 2.59M |
| Simris Group AB (PUBL) | 1.88M |
Alzinova AB News
- 2 months ago - Alzinova AB Quarterly report: Q1 2026 - Filings
- 4 months ago - Alzinova AB Quarterly report: Q4 2025 - Filings
- 4 months ago - Alzinova AB Annual report: Q4 2025 - Filings
- 9 months ago - Alzinova AB Quarterly report: Q3 2025 - Filings
- 10 months ago - Alzinova AB Transcript: Investing in Life Science 2025 - Transcripts
- 1 year ago - Alzinova AB Quarterly report: Q2 2025 - Filings